• LAST PRICE
    69.5500
  • TODAY'S CHANGE (%)
    Trending Down-0.9000 (-1.2775%)
  • Bid / Lots
    49.0000/ 5
  • Ask / Lots
    111.4000/ 2
  • Open / Previous Close
    70.9900 / 70.4500
  • Day Range
    Low 69.0200
    High 70.9900
  • 52 Week Range
    Low 27.2800
    High 75.1000
  • Volume
    336,356
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 70.45
TimeVolumeACLX
09:32 ET168670.99
09:39 ET10070.31
09:45 ET35970.4
09:48 ET20070.22
09:54 ET60070.375
09:56 ET10070.38
09:59 ET10070.17
10:01 ET30070.195
10:03 ET40070.295
10:06 ET10070.06
10:08 ET10070.165
10:10 ET50069.77
10:12 ET20069.76
10:14 ET30069.675
10:15 ET10069.715
10:17 ET60069.54
10:19 ET60069.7596
10:21 ET30069.715
10:26 ET50069.69
10:30 ET10069.6
10:32 ET20069.64
10:33 ET20069.665
10:35 ET110069.89
10:37 ET150070.09
10:39 ET10070.18
10:44 ET10070.095
10:48 ET91169.815
10:50 ET60069.84
10:55 ET100069.65
10:57 ET70069.73
11:00 ET10069.83
11:02 ET63769.765
11:04 ET30069.78
11:06 ET40069.76
11:08 ET50069.765
11:09 ET20069.795
11:11 ET10069.795
11:13 ET80069.94
11:15 ET40070.035
11:18 ET60070.09
11:20 ET10070.205
11:22 ET10070.09
11:24 ET120070.37
11:26 ET10070.465
11:27 ET243170.62
11:29 ET168170.43
11:31 ET20070.42
11:33 ET20070.3
11:36 ET20070.23
11:38 ET100070.23
11:40 ET30070.23
11:45 ET60070.14
11:47 ET80070.08
11:49 ET449670.01
11:51 ET30070.02
11:54 ET120870.09
11:56 ET42269.95
11:58 ET20969.97
12:00 ET60069.75
12:02 ET128069.72
12:03 ET128069.77
12:05 ET284269.945
12:07 ET200069.91
12:09 ET31770.025
12:12 ET20170.05
12:14 ET131470.15
12:16 ET10070.14
12:20 ET10070.1
12:25 ET60870.01
12:30 ET10070.04
12:32 ET243870.01
12:34 ET94570
12:36 ET190870.01
12:38 ET42770.01
12:39 ET121269.975
12:41 ET21470.01
12:43 ET210470.02
12:45 ET30669.975
12:48 ET791569.945
12:52 ET60069.94
12:54 ET50069.95
12:56 ET50070.05
12:57 ET31370.01
12:59 ET326069.31
01:01 ET10069.38
01:03 ET90069.075
01:06 ET50069.19
01:10 ET104369.405
01:14 ET100469.315
01:17 ET30069.12
01:21 ET10069.16
01:24 ET198269.12
01:26 ET80069.27
01:28 ET10069.17
01:30 ET10069.2
01:32 ET40069.09
01:33 ET81169.12
01:35 ET275069.15
01:39 ET37769.12
01:42 ET10069.125
01:44 ET20069.12
01:46 ET20069.12
01:48 ET10069.14
01:51 ET317869.08
01:53 ET221169.28
01:55 ET10069.21
01:57 ET56269.315
02:00 ET30069.38
02:02 ET10069.43
02:04 ET40069.37
02:06 ET130069.285
02:08 ET70069.44
02:09 ET34069.54
02:11 ET91869.41
02:18 ET10069.38
02:20 ET70069.3
02:22 ET170069.1
02:26 ET20069.105
02:27 ET61769.17
02:29 ET50069.25
02:33 ET20069.17
02:36 ET40769.14
02:38 ET171369.095
02:40 ET113069.2
02:44 ET360069.35
02:45 ET253069.41
02:47 ET75869.395
02:49 ET198969.52
02:51 ET20069.49
02:54 ET10069.51
02:56 ET90069.53
02:58 ET60069.72
03:00 ET10069.76
03:02 ET501769.77
03:03 ET20069.87
03:05 ET20069.66
03:07 ET130869.85
03:09 ET132470.04
03:12 ET60070.21
03:14 ET40070.29
03:16 ET110070.13
03:18 ET20070.2
03:20 ET150069.97
03:21 ET10069.82
03:23 ET20069.665
03:25 ET167069.76
03:27 ET10069.655
03:30 ET209269.72
03:34 ET20069.63
03:36 ET50069.56
03:38 ET180069.67
03:39 ET20069.745
03:41 ET30069.69
03:43 ET60069.665
03:45 ET177669.71
03:48 ET143669.79
03:50 ET70069.71
03:52 ET140869.71
03:54 ET346969.89
03:56 ET340069.775
03:57 ET212569.65
03:59 ET547169.55
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesACLX
Arcellx Inc
3.7B
-46.8x
---
United StatesALVO
Alvotech SA
3.4B
-5.1x
---
United StatesSWTX
SpringWorks Therapeutics Inc
3.7B
-9.6x
---
United StatesIBRX
Immunitybio Inc
3.7B
-4.8x
---
United StatesAPGE
Apogee Therapeutics Inc
3.9B
-38.2x
---
United StatesIOVA
Iovance Biotherapeutics Inc
3.9B
-7.8x
---
As of 2024-03-29

Company Information

Arcellx, Inc. is a clinical-stage biotechnology company. The Company is focused on the development of controllable cell therapies for the treatment of patients with cancer and other incurable diseases. The Company’s lead program is a BCMA-targeting ddCAR product candidate called CART-ddBCMA, which is being evaluated in its pivotal Phase II iMMagine-1 trial in patients with relapsed or refractory multiple myeloma (rrMM). The Company is also developing two clinical-stage ARC-SparX programs in Phase I trials; ACLX-001, which targets BCMA in rrMM, and ACLX-002, which targets CD123 in relapsed or refractory acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). Outside of multiple myeloma (MM), the Company advances its wholly owned portfolio of clinical-stage, ACLX-002, and preclinical pipeline programs incorporating its D-Domain technology. D-Domain, is designed to overcome the limitations of traditional Chimeric Antigen Receptor T-cells (CAR-Ts).

Contact Information

Headquarters
800 Bridge ParkwayREDWOOD CITY, CA, United States 94065
Phone
240-327-0603
Fax
302-655-5049

Executives

Chairman of the Board, President, Chief Executive Officer
Rami Elghandour
Chief Financial Officer
Michelle Gilson
Chief Medical Officer
Christopher Heery
Chief Commercial Officer
Neeraj Teotia
Independent Director
Ali Behbahani

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$3.7B
Revenue (TTM)
$110.3M
Shares Outstanding
52.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-1.49
Book Value
$9.28
P/E Ratio
-46.8x
Price/Sales (TTM)
33.7
Price/Cash Flow (TTM)
---
Operating Margin
-81.47%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.